SLC5A2 and atrial fibrillation: Further research is needed for exploring the dose-specific effect and the underlying mechanisms of individual SGLT2 inhibitors, comparing their efficacy with other potentially AF-protective medications, and validating the long-term benefit of SGLT2 inhibitors in diverse populations.